Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

Today’s headlines highlight critical developments in genetic medicine, global politics, and the latest updates from the ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Another exciting area of personalized medicine is using nanotechnology for gene therapy. Gene therapy involves altering or ...

Australian cancer researchers are the first to establish a next-generation gene-editing tool for modelling and interrogating human disease.

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

PFG Investments LLC lifted its stake in CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 9.9% in the 4th quarter, ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Exchange Traded Concepts LLC trimmed its holdings in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 16.0% during the fourth quarter, according to the company in its most recent Form ...